Try our Advanced Search for more refined results

Novartis To Allow Leukemia Drug Generics In Some Areas

By Adam Lidgett ( October 20, 2022, 7:18 PM EDT) -- Pharmaceutical companies in about half a dozen countries will be allowed to make generic versions of a leukemia drug made by pharma giant Novartis, helping to boost the ability of patients to get their hands on the treatment, according to the Medicines Patent Pool....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!